Top 50 Health Care VC (Venture Capital) Funds in Germany in October 2024
A list of 50 VC (Venture Capital) funds that invest in Health care startups based in Germany. We rank investors based on the number of investments they made in Health care companies from Germany. We update this investor list every month.Top 50 Health Care VC (Venture Capital) Funds in Germany in October 2024
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Series A, Funding Round
- Germany, Switzerland, United States
Portfolio highlights
- Samp — Samp accelerates modernization and de-risks contracts by connecting outdated drawings with current 3D reality captures of your facilities using our AI.
- become.1 — become.1 is an employee benefits platform that eliminates the complexity of tax regulations for employees.
- Symphera — An all-in-one surgical system that makes minimally-invasive procedures more efficient.
IBB Ventures is a venture capital and mezzanine arm of Investitionsbank Berlin specializing in seed/startup, early venture, and mid venture investments. The firm invests in technology-oriented companies and companies from the creative industries. It typically invests in information and communication sector with a focus on hardware andsoftware, network technology, new media, and internet and mobile technologies; life science sector with a focus on biotechnology and media technology; and industrial technologies sector with a focus on software, PPS, supply chain management, micro and nanotechnology, environmental and power technology, automation, manufacturing technology, transport technology and logistics, and new materials. The firm also invests in movies, broadcast, television, publisher, music, entertainment, advertising, fashion, design, architecture, multimedia, games, software, and art and culture. It invests in companies based in Berlin. It typically invests between €0.25 million ($0.32 million) and €3 million ($3.83 million) per transaction. The firm prefers to take a board seat in its portfolio companies. IBB Ventures was founded in 1997 and is based in Berlin, Germany.
Show more
Investment focus
- Software, Health Care, Internet
- Seed, Funding Round, Series A
- Germany, United States, United Kingdom
Portfolio highlights
- eco.mio — eco.mio enables companies to reach their climate targets while realizing significant savings: Incentivize employees to travel consciously with eco mio's end-to-end integrated software solution.
- Ucaneo — We Leveraging the magic of the human body to remove CO2 from the air.
- Northbound — We are building the dynamic decision engine that translates real-time data into operational excellence & stakeholder transparency. All at the intersection of warehouse and transport logistics.
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Funding Round
- Germany, United States, Finland
Portfolio highlights
- Symphera — An all-in-one surgical system that makes minimally-invasive procedures more efficient.
- SPiNE — SPiNE is a startup that provides safe, clean, and inexpensive energy to all end users. It is focused on smart meter rollout and, as a result, digitalization in metering and control of charging infrastructure, heat pumps, and battery storage.
- Marvel Fusion — Our mission is to enable humankind to access clean, safe & reliable energy by building a laser-driven fusion power plant.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Pre-Seed
- Germany, Switzerland, United States
Portfolio highlights
- Again — SecondCircle makes carbon negative chemicals for a cleaner future. We are the first carbon negative chemical manufacturer that can scale to meet global demand. The best thing about it: we use carbon dioxide as a feedstock.
- SynthFlow AI — Build AI Agents at Scale. No Coding Required.
- SCRYPT Digital — Your trusted partner for crypto assets
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Seed, Series A, Series B
- Germany, United States, Switzerland
Portfolio highlights
- Vara — Vara develops a breast cancer screening platform powered by AI for radiologists, allowing them to focus on finding cancer early. While we provide. Vara also provides remote mammography reading services to those that lack the radiologists. Vara's mission is to make affordable diagnostics available all over the world by designing machinelearning-powered workflows that users love to work with.
- anvajo — Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof.
- Navignostics — Navignostics combines highly multiplex tumor imaging with advanced data analytics for personalized cancer treatments.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Funding Round, Series A, Series B
- Germany, India, Kenya
Portfolio highlights
- Uniper — Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assetsinto a separate company that began operating on 1 January 2016.
- Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
- Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more
Investment focus
- Software, Information Technology, Manufacturing
- Seed, Funding Round, Series A
- Germany, United States
Portfolio highlights
- In.hub — in.hub is a specialist in condition monitoring of machines, processes, and products, offering digitalisation options in the industrial environment. It connects legacy and modern systems, creates condition monitoring systems, and generates information for optimal planning and control.
- Packwise — Packwise is bringing Intermediate Bulk Containers (IBCs) to the Internet of Things. Their Packwise Smart Cap makes a container intelligent and allows for improved and automated packaging management and logistics. Millions of IBCs are being used by chemical, pharmaceutical and food companies every day. Their Packwise Smart Cap is narrow-band LPWANconnected and provides users with real-time information on the state and location of containers.Packwise develops ready-to-use web applications and can be integrated with existing in-house IT or software through web service API.Packwise GmbH is a German company based in the Silicon Saxony. Packwise is Europe’s pioneer in digital industrial packaging management (IBCs and drums).
- watttron — Watttron invents a revolutionary heating system that can heat up surfaces heterogeneously.Watttron develops an innovative heating technology that can be used in various industrial processes. It is superior to current heating systems in many ways and offers a number of advantages. On the following pages, you will find information about possibleapplications and opportunities.The company is located in the Technologie- und Gründerzentrum Freital – a technology and start-up center on the outskirts of Dresden, the state capital of Saxony.
We support exceptional founders in building market leading digital companies.
Show more
Investment focus
- E-Commerce, Internet, Software
- Series A, Seed, Series B
- Germany, United Kingdom, United States
Portfolio highlights
- Delli — We're a company just starting out on our mission to make good food accessible and enjoyed by all.
- Again — SecondCircle makes carbon negative chemicals for a cleaner future. We are the first carbon negative chemical manufacturer that can scale to meet global demand. The best thing about it: we use carbon dioxide as a feedstock.
- Marvel Fusion — Our mission is to enable humankind to access clean, safe & reliable energy by building a laser-driven fusion power plant.
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more
Investment focus
- Health Care, Wellness, Software
- Seed, Pre-Seed, Series A
- Germany, United Kingdom, Austria
Portfolio highlights
- Propcorn — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- Linq — The safest way to send intimate content
- Meela — Meela AB matches individuals with psychologists or psychotherapists for online and in-person therapy.
Zusammen gestalten wir die Unternehmen von morgen.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Germany, France, Austria
Portfolio highlights
- Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
- SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
- Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.
APX is Europe’s leading very-early-stage VC. Based in Berlin and backed by Axel Springer and Porsche, we support and partner with the most ambitious founding teams from Europe and beyond - often as their first investor.We invest up to EUR 500K in startups until a series A starting with a quick EUR 50K investment, and within a few months,depending on traction and speed, we can invest further. Each month we invest in new teams who become part of the APX community, counting hundreds of other founders. Since 2018, we have invested in 100+ startups across 20+ industries with founders from 20+ countries together with 100+ co-investors.
Show more
Investment focus
- Software, SaaS, Information Technology
- Pre-Seed, Seed, Series A
- Germany, United Kingdom, United States
Portfolio highlights
- Spike Technologies — November 30, 2022 - Spike technology, REST API end-points, and Cloud architecture are designed with data privacy and security at heart. We process billions of
- Eleos — Get income protection insurance online with Eleos. All policies include 24x7 Virtual GP, gym discounts and other benefits.
- DC Connected — Mobility Enhancement Platform
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
- Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
- Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more
Investment focus
- Biotechnology, Software, Information Technology
- Seed, Series A, Series B
- Germany, United States, United Kingdom
Portfolio highlights
- widu — widu enables real estate and accommodation companies to source visuals (photography, video, drone) at scale through its serviced marketplace
- Black Semiconductor — Black Semiconductor manufacture microchips with integrated electronic-photonic circuits using graphene technology.
- Prothea Technologies — Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more
Investment focus
- Software, Health Care, Artificial Intelligence
- Series A, Seed, Series B
- Germany, Switzerland, United Kingdom
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- Atlas Metrics — The single source of truth for your ESG data
- Marvel Fusion — Our mission is to enable humankind to access clean, safe & reliable energy by building a laser-driven fusion power plant.
Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.
Show more
Investment focus
- Software, E-Commerce, Internet
- Seed, Series A, Pre-Seed
- Germany, United States, Poland
Portfolio highlights
- NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
- MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
- Akhetonics — Creating the first all-optical RISC Processor
They are a group of friends and internet/tech entrepreneurs who first met ten years ago in Saarbruecker Strasse 21 in Berlin Prenzlauer Berg. All of them started successful businesses, they are founders and share a passion for building great companies. As active business angels, they also invest in young startups, either individually orcollectively as a group. They provide seed funding for killer-founders and great ideas. But way more important: they help to avoid mistakes that they have already made . They introduce to the right people. They provide with all the experience that they have. Not just talking about it but helping hands-on.
Show more
Investment focus
- Software, Internet, E-Commerce
- Seed, Pre-Seed, Angel
- Germany, United States, Israel
Portfolio highlights
- Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
- a2zebra — a2zebra is a zebra company that specializes in instructional technology for elementary school kids.
- Seqstant — Seqstant offers the LiveGene platform for real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Funding Round
- Germany, United States, United Kingdom
Portfolio highlights
- SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
- UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.
- Onward — Working to restore movement, independence, and health in people with spinal cord injury.
Investing early in Europe's most passionate founders.
Show more
Investment focus
- Health Care, Financial Services, Software
- Seed, Series A, Funding Round
- Germany, Austria, United Kingdom
Portfolio highlights
- LiveEO — LiveEO is the leading solution provider for AI-powered satellite-based monitoring of large infrastructure networks. Trusted worldwide.
- OneTwenty — OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes.
- HealthCaters — HealthCaters is a connected care solution for companies that allows them to empower their employees to take control of their health.
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Funding Round, Grant
- Germany, United States
Portfolio highlights
- 3D Spark — Profitability and Sustainability Aligned using 3D Spark's Platform - Empowering Manufacturing with Insights and Efficiency!
- Stargazr — Stargazr is a AI-powered software that enables you to understand your financial data
- Neuralfinity — Neuralfinity provides computer AI services. They generalise machine learning models by utilising an ML API as a service.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Seed, Series A, Series B
- Denmark, Germany, United States
Portfolio highlights
- Skynopy — Connecting satellites. As a service
- MAJORITY — MAJORITY is the first digital financial service dedicated to serving migrants worldwide. For $5 a month, MAJORITY members in the U.S. receive an FDIC-secured account, VISA® debit card, use of more than 55,000 ATMs across North America, remittance and international calling, native language advisors, and access to our network of community meet-upspaces, local discounts and events. With MAJORITY, there are never overdraft fees or minimum balance requirements. MAJORITY was started in Sweden by a diverse team of banking, fintech, payments, and telecom executives serving immigrant communities globally for the last 15 years. MAJORITY’s U.S. headquarters are in Houston, Texas.
- Natural Cycles — Natural Cycles birth control is 93% effective with typical use and 98% effective with perfect use. Learn more about hormone-free birth control today.
bmp Ventures is an innovative Venture Capital Company from Berlin.
Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more
Investment focus
- Information Technology, Software, Manufacturing
- Seed, Funding Round, Series A
- Germany, United States, Austria
Portfolio highlights
- Neotiv — Enabling cognitive health
- RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
- XenoPatch GmbH — First-ever portable device for pain management, seamlessly combines heat, cold and vibration treatment with an intuitive smartphone app.
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Funding Round, Series A
- Germany, United States
Portfolio highlights
- tediro — tediro develops a mobile robotics platform for multiple applications in healthcare primarily therapy and diagnostics
- Enginsight — Enginsight GmbH was founded in August 2017. With a highly motivated team, they are working together on the vision of providing companies with a solution that will enable them to safely and confidently navigate the digital future. Enginsight helps leading companies autonomously monitor and secure their entire IT landscape. Certified and highlytrained employees form the heart of Enginsight, together with partner companies around the globe. They analyze and monitor complete IT landscapes – recognize the connections and dependencies between websites and servers up to IoT-devices. The innovative software platform acts autonomously and points out the critical paths, risks and threats.
- Coachwhisperer — Coachwhisperer: The live communication system for sports. We take training to the next level and help coaches and athletes reach their true potential.
Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.
Show more
Investment focus
- Software, SaaS, Health Care
- Seed, Pre-Seed, Series A
- Germany, Austria, Switzerland
Portfolio highlights
- Briink — Our AI helps private equity firms and companies automate and scale their EU Taxonomy and SFDR assessments. Get in touch today.
- mogenius — mogenius radically simplifies cloud infrastructure for software developers. The code to cloud platform provides a completely automated workflow of deploying an application in Kubernetes - with hyperscale cloud resources, built-in CI/CD and DDoS protection so you can start coding in seconds. Never waste time on complicated, error-prone, andrepetitive configurations in your cloud infrastructure again, and focus on what you really love: building great applications.
- Enginsight — Enginsight GmbH was founded in August 2017. With a highly motivated team, they are working together on the vision of providing companies with a solution that will enable them to safely and confidently navigate the digital future. Enginsight helps leading companies autonomously monitor and secure their entire IT landscape. Certified and highlytrained employees form the heart of Enginsight, together with partner companies around the globe. They analyze and monitor complete IT landscapes – recognize the connections and dependencies between websites and servers up to IoT-devices. The innovative software platform acts autonomously and points out the critical paths, risks and threats.
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Series A, Series B
- Germany, Italy, United States
Portfolio highlights
- memtime — memtime shows you everything you worked on during the day. Each program is recorded so that you can quickly remember. Add-on available for any software. | memtime
- StoryBox — StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM.
- Kloster Kitchen — Kloster Kitchen is a monastery kitchen as the root of unique taste.
Cherry Ventures is an early-stage venture capital firm led by a team of entrepreneurs with experience building fast-scaling companies such as Zalando and Spotify. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from their go-to-market strategy and the scaling of theirbusinesses. Cherry Ventures has previously invested in the seed stage of over 50 companies across Europe, including FlixBus, Auto1 Group, Infarm, Rows, Forto, and TourRadar. Cherry Ventures is based in Berlin and invests across Europe with operations in London, Paris, and Stockholm.
Show more
Investment focus
- Software, Financial Services, Information Technology
- Seed, Series A, Series B
- Germany, United Kingdom, United States
Portfolio highlights
- Qura — Qura builds AI to make legal text searchable using natural language.
- Atlas Metrics — The single source of truth for your ESG data
- bunch — bunch is the operating system (OS) for private market investing, handling digital entity creation, seamless investor onboarding and portfolio management. The company's platform focuses on saving time, money and mental energy by eliminating legacy intermediaries, overwhelming regulatory complexity, and low-tech administration.Operating acrosslegal structures, asset classes and jurisdictions allows bunch to fully unlock private markets for everyone, enabling businesses and investors to make private markets easy, cost-efficient and fast.
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Funding Round
- Germany, United Kingdom
Portfolio highlights
- Mateo — Mateo is the omni-channel customer experience powerhouse that empowers local brands and businesses to drive growth through a digital customer lifecycle management. From acquiring new leads, converting them into customers and extending those relationships - all in one platform.
- family.cards — Family.cards provides elders with barrier-free access to digital solutions and all the tools they need to manage their circumstances.
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more
Investment focus
- Health Care, Software, Information Technology
- Seed, Funding Round, Series A
- Germany, United Kingdom, Finland
Portfolio highlights
- Ovom Care — Enabling every individual to become a parent.
- Quantistry — Revolutionize your R&D with QuantistryLab. Explore 100 million structures and run your own simulations from Quantum to AI. Get started today!
- Decade Energy — Decade is the energy transition partner for fleet operators and depot managers looking to deploy an electric fleet.
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more
Investment focus
- Financial Services, FinTech, Software
- Seed, Series A, Pre-Seed
- Germany, United States, United Kingdom
Portfolio highlights
- Blitzy — You Describe It, We Build It
- Jet HR — Jet HR makes managing people incredibly simple: payroll, benefits, devices, compliance and much more. We re-thought the HR function, removing anything that is cumbersome and simplifying any action on employees. We are funded by the best Italian VCs (Exor Ventures, Italian Founders Fund and 6 more) and by the best Italian founders (founders ofCasavo, Satispay, Scalapay, Bending Spoons, Musixmatch, Talent Garden, Oyster HR, etc).
- Landbase — Landbase combines leading agentic AI with human expertise to intelligently automate your Go-To-Market
Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more
Investment focus
- Software, SaaS, FinTech
- Series A, Seed, Series B
- Germany, Switzerland, United States
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Series A, Seed, Series B
- Germany, Switzerland, United Kingdom
Portfolio highlights
- Lakera AI — Lakera Guard empowers organizations to build GenAI applications without worrying about prompt injections, data loss, harmful content, and other LLM risks. Powered by the world's most advanced AI threat intelligence.
- ExpressionEdits — Redefining the status quo of protein expression
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
YZR Venture Capital is a vertical Venture Capital Fund backing Health Tech Entrepreneurs.
Show more
Investment focus
- Health Care, Software, Artificial Intelligence
- Seed, Pre-Seed, Funding Round
- Germany, Poland, Finland
Portfolio highlights
- Deemea — Deemea is a collaborative AI platform that connects and provides services for the analysis of medical data for physicians. It uses its expertise in clinical research, data science, and software development to help healthcare professionals.
- Clare&me — Clare is your virtual coach which calls you whenever you want and wherever you are. Stigma free phone calls and messaging based on cognitive- behavioral therapy. clare&me supports you on your self-help journey to better sleep, less worry and more self-confidence.
- Esper Bionics — Solutions to transform the prosthetic industry and augment humanity
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Series A, Funding Round, Series B
- Germany, Switzerland, United States
Portfolio highlights
- Ledgy — Digitize your cap table, automate equity plans and simplify compliance. Find out how leading companies use Ledgy to empower their employees and engage investors.
- HeyJobs — Intelligent recruiting | more hires with performance marketing | only qualified candidates | fast recruiting success | over 1,500 companies use HeyJobs to find employees
- Humanoo — HUMANOO | MAKING PEOPLE HEALTHIER! HUMANOO is the digital health platform for employees and insurance clients. We enable our users to improve their physical and mental health. Simple, effective, proven - all in one app. With customized programs and innovative eHealth solutions, we guide our users in the areas of fitness, physio, yoga, mindfulnessand nutrition to their self-imposed goals. For the first time, companies and insurance companies can use comprehensive decentralized analysis to understand the health of their employees or insurance clients and make it a measurable success. Our team currently consists of 65 employees from 15 nations with different talents. In our office in Berlin-Kreuzberg, software developers, designers, marketing and sales specialists work together with sports and nutrition scientists as well as yoga teachers and physiotherapists. What we share is the goal to motivate people to stay healthy.
Springboard Health Angels is a Berlin based Angel group to invest in early stage Digital Health startups
Show more
Investment focus
- Health Care, Software, Biotechnology
- Seed, Pre-Seed, Funding Round
- Germany, United States, Sweden
Portfolio highlights
- deepeye — 66% of blindness in Europe and the US is caused by retinal diseases - and thus preventable.
- PharmaCCX — Welcome to CCX - digital tools purposely-built for market access. Explore our 4 transformative tools, and industry-leading expertise.
- Every Health — Every Health focuses on "holistic, needs-based medical care for the LGBTQIA+ community".
Vorwerk Ventures is an independent €150m Venture Capital Fund grown out of the Vorwerk Group in late 2019 and defines itself through a strong commitment towards consumer-facing digital businesses. Our unique direct selling experience in addition to an outstanding track record in Venture Capital provides added value for forward-thinkingentrepreneurs. Headquartered in Berlin Germany, we currently have more than €250m in assets under management and are constantly on the look-out for promising opportunities starting with Seed/Series A investments of €1m to €10m and ensuring continuous support reserving up to €15m for upcoming financing rounds. An outstanding founding team, an existing market presence and a well-defined exit strategy framed by a consumer-centric business model are key requirements to us when it comes to making an investment decision.
Show more
Investment focus
- E-Commerce, Health Care, Food and Beverage
- Seed, Series A, Series B
- Germany, United Kingdom, Switzerland
Portfolio highlights
- Sunhero — Sunhero delivers custom-built solar panel solutions. Sunhero offers consumers a hassle-free method of installing customised photovoltaic solar systems on their homes, be that either purchasing outright or renting for a 20 year period.
- CarbonPool — Innovative carbon credit insurance which pays claims in carbon credits, not cash. See how we can help you.
- Sorella Care — Sorella is the first network of multidisciplinary health places for women. Sorella ensures that every woman, regardless of age, has access to a comprehensive care pathway offered by women's health specialists.
468 Capital is a Berlin and San Francisco based technology investment firm. We support leading software, AI and internet growth companies across multiple investment stages.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Germany, United States, Singapore
Portfolio highlights
- Cartken — Launch your robot fleet with us. The AI powering our robots makes them the safest and most reliable in the market today.
- KARRI — KARRI is a data and GPS enabled, screen-free device for easy communication between you and your kids. A KARRI for your child and a smartphone app for you - it's as simple as that.
- Morningcrunch — Morning Crunch provides daily email briefings on business-related economic and financial topics. The company provides succinct, bullet-point reports that condense the most significant market and investment information for young professionals to read in under five minutes.
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- Switzerland, Germany, France
Portfolio highlights
- Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.
Show more
Investment focus
- Health Care, Artificial Intelligence, Machine Learning
- Seed, Series A, Series B
- Germany, Canada, Poland
Portfolio highlights
- PeakData — PeakData is a software platform to identify and analyze key opinion leaders in your therapeutic area. PeakData is making sense of the data spread across the web by using the latest developments of AI.
- Avi Medical — Avi Medical is a digital health care company that provides telemedicine services. Its platform enables patients to book appointments, manage their health data, and chat with the practitioner. The company uses data-driven medicine to provide patients and healthcare workers with a streamlined, more modern experience.
- Spotlight Medical — Spotlight Medical is a precision medicine company striving to free all patients from cancer through a better understanding of each patient’s unique disease. We develop advanced AI tests that enhance treatment selection by leveraging decades of patient data. This ensures personalized and effective care for each individual, significantly improvingpatient outcomes and quality of life. By closely collaborating with physicians, we create impactful tests that address critical unmet clinical needs, opening a new era in cancer care.
Target Global is a prominent European technology investment firm with a significant presence in the venture capital landscape, boasting over €3 billion in assets under management. The firm operates out of key tech hubs including London, Berlin, Tel Aviv, and Abu Dhabi, and has a rich portfolio featuring some of Europe's most successful techcompanies such as Revolut, Auto1, Copper, Delivery Hero, Docplanner, and Rapyd.Founding and GrowthTarget Global was established in 2015 by Shmuel Chafets and Yaron Valler, who brought a wealth of experience from their tenure at Hasso Plattner Ventures. Their professional partnership dates back 15 years to their time at Giza Venture Capital, a trailblazer in Israel's investment ecosystem, where they honed their investment acumen and industry foresight.Investment Philosophy and ImpactTarget Global stands out in the European tech industry for its diverse team and its ability to identify and capitalize on unique opportunities. The firm's knack for recognizing potential in the early stages of Germany's tech economy led to the emergence of several unicorns in the 2010s. As the European tech industry evolves, Target Global remains at the forefront, seeking out innovative companies like Robovision, Saleor, and Finom. These recent investments reflect the firm's commitment to supporting cutting-edge technology and business models.Fundraising SuccessesTarget Global's fundraising prowess is evident in its six investment funds, which have collectively raised significant capital. The funds range from Early Stage Funds, focusing on nascent startups, to Growth Funds that support more mature companies scaling their operations. The firm's co-investment strategy has led to over €1 billion in capital deployment across a diverse array of partnerships.Backing and AchievementsWith the backing of investors such as FERI, UBS, Allianz X, Mubadala, and Hermes GPE, Target Global has cemented its reputation as a trusted and successful investment firm. Its portfolio spans over 140 companies at various development stages, with a focus on those targeting trillion-dollar markets.Just a few of the many notable companies in the firm’s portfolio include:- Tarabut, MENA’s leading open banking platform, which was recently featured in Forbes Middle East’s list of Top 50 Fintech Companies.- Flo Health, an AI-driven women’s health product, which is the world’s top health and fitness app by downloads.- Robovision, an easy-to-use AI-driven computer vision platform for users to develop their own deep-learning-based solutions.- Enter, a German company that helps homeowners and businesses reduce their carbon footprint.Target Global's track record includes support for 15 unicorn companies, over 20 exits, and 7 IPOs, showcasing its ability to drive growth and success in the European tech ecosystem. The team, comprised of individuals with founder and operator backgrounds, continues to pursue exceptional opportunities to expand the firm's portfolio and influence.Target Global's journey from its inception to its current status as a key player in European venture capital is marked by strategic investments, a commitment to diversity, and a deep understanding of the tech industry's dynamics. With a clear vision for the future, Target Global is poised to continue its role in shaping the next wave of European tech giants.
Show more
Investment focus
- FinTech, Financial Services, Software
- Series A, Seed, Series B
- Germany, Israel, United Kingdom
Portfolio highlights
- Palm — Cash Management for the Modern Treasury
- MagnusMetal — Magnus_Metal - Digital Era has arrived for Metal Casting. MagnusMetal team is taking casting, a 6000 years old technology, to the digital Industry 4.0 era, with our breakthrough patent pending, volume alloy Digital Casting System and process
- Essor — Branded is a startup company that acquires and partners with top-performing Amazon sellers and brands.The company emerged from stealth and its goal is to acquire proven Amazon brands and grow them by 100x by applying expertise in marketing, supply chain, merchandising, and product development. It collects a portfolio of best-selling andprofitable brands in the home, leisure, and lifestyle category with over 700,000 reviews on Amazon’s marketplace and collectively generating $150 million in gross revenue. Branded's backer includes Target Global, Declaration Partners, Tiger Global, Kreos Capital, Lurra Capital, Regah Ventures, Kima Ventures, and Vine Ventures.It was launched by Pierre Poignant, Michael Ronen, and Ben Kaminski in Paris, Ile-de-France in 2020.
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation.
The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Private Equity, Funding Round
- France, United States, Germany
Portfolio highlights
- SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
- Skysun — Skysun is a financial institution that provides financial solutions and services to the solar energy sector.
- Kestra Medical Technologies, Inc. — Kestra Medical Technologies is a wearable medical device and digital healthcare company that protects patients with diagnostic and therapeutic technologies that are intuitive, and mobile. They provide intuitive medical technologies to protect and support at-risk patients.
Impacting the future of medicine.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
- Navigator Medicines — Leading the advancement of biologics for targeted immune regulation & restoration.
- Bicycle Therapeutics — Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more
Investment focus
- Software, Information Technology, SaaS
- Pre-Seed, Seed, Series A
- Singapore, United Kingdom, Australia
Portfolio highlights
- FitFlo — FitFlo brings to life the connected gym experience for Operators, Trainers and Members.
- Mole — Mole is a digital business card and mobile website software. Connect with your clients, promote your business online and much more. Comes with free customised NFC business card.
- Optacloud — Fostering a global AI powered ecosystem to achieve 100% cloud efficacy-> effortlessly, economically and eco-consciously. Dev tools stack for automating the entire development lifecycle of cloud apps across- Build, Deploy & Optimize.
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Funding Round
- Germany, Finland, France
Portfolio highlights
- Exein — Exein provides the most advanced IoT security solution to protect your devices and containers. Protect your IoT devices in real time and at scale.
- Carbonx — CarbonX is your trusted carbon credits procurement and management partner for high-quality permanent carbon dioxide removals to reach your net zero targets.
- Atlas Metrics — The single source of truth for your ESG data
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, The Netherlands, Switzerland
Portfolio highlights
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- PanTera — PanTera wants to bring a new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for personalised treatment of tumors
- Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Pre-Seed
- United States, Germany, United Kingdom
Portfolio highlights
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- ExpressionEdits — Redefining the status quo of protein expression
- Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Pre-Seed, Series A
- Germany, Australia, United States
Portfolio highlights
- Insempra — Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance.
- Sumday — Non - financial accounting software. Start carbon accounting, properly, with the support of your existing advisors
- InSpacePropulsion Technologies — ISPTech is a Spin-Off of the Institute of Space Propulsion at the German Aerospace Center (DLR). It offers non-toxic, green propulsion solutions
WestTech Ventures is a Berlin-based VC firm focused on pre-seed & seed investments primarily in Germany in the fields of B2B SaaS in different verticals, and Enterprise Software as well as Mobility and New Work.
Show more
Investment focus
- Software, Internet, Information Technology
- Seed, Series A, Funding Round
- Germany, United States, France
Portfolio highlights
- Notch — Boost your deal win rates and customer onboarding with Notch. Create tailored buyer experiences, structured action plans, and gain valuable insights. Try our demo today.
- Careloop — Berlin-based HR-tech and EduTech startup with a focus on the German healthcare industry.
- THE CLIMATE CHOICE — The software platform for decarbonizing companies and their supply chains.
The EnjoyVenture Management is a private equity company that focuses its investments on the seed and early-stage companies.
Show more
Investment focus
- Software, E-Commerce, Information Technology
- Seed, Series A, Funding Round
- Germany, Portugal, United States
Portfolio highlights
- coapp — coapp brings people and resources together under your brand and handles social and financial transactions between them. Easy!
- MARCLEY — MARCLEY provides a system that enables multi-family building apartment owners to utilize solar energy on their roofs without any financial commitment or additional effort. The generated green power is sold at a cheaper cost than the local basic utility.
- Careloop — Berlin-based HR-tech and EduTech startup with a focus on the German healthcare industry.
We help brilliant teams with a strong moat to establish visionary market leaders.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series A, Seed, Series B
- Germany, Switzerland, United Kingdom
Portfolio highlights
- Oska Health — Oska Health delivers digital-enabled care solutions for chronic kidney disease patients, a top clinical need for healthcare payers. By leveraging evidence-based medical best practices and behavioral science, Oska Health aims to empower individuals with kidney disease to mitigate their risk of cardiovascular complications and kidney failure whilesimultaneously lowering costs of care. The company partners with healthcare payers to provide a comprehensive solution that includes a personal coach, a state-of-the-art health app, and intelligent treatment plan algorithms, all designed to help individuals establish new routines and achieve optimal health outcomes.
- specter automation — Construction is the second least digitized sector in the world with 96% of all data being unused. Although detailed planning data is created upfront, a lack of suitable digital tools prevents its transfer to the construction site. SPECTER’s web-based construction management software uniquely incorporates the core components of constructionplanning, reducing the organizational burden on construction management and helping to meet project timelines and budgets.
- Heidelberg Epignostix — Heidelberg Epignostix is a pioneering start-up led by a dedicated team of DNA methylation-based tumor categorization experts. Heidelberg Epignostix has revolutionized tumor categorization by using the strength of methylation-based algorithms.
We ideate, build and scale the next category leaders in artificial intelligence. Join our global network of researchers, entrepreneurs and investors to explore the potentials AI together.
Show more
Investment focus
- Machine Learning, Artificial Intelligence, Health Care
- Seed, Pre-Seed, Series A
- Germany
Portfolio highlights
- Ovom Care — Enabling every individual to become a parent.
- Addera Health — We build AI coaches that hyper-personalize mental health, starting with adult ADHD
- Graph Therapeutics — Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are leftwithout adequate treatment options - and AI trained with complex disease data can solve this.
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more
Investment focus
- Software, Information Technology, Health Care
- Series A, Seed, Series B
- Germany, United States, United Kingdom
Portfolio highlights
- Draftwise — DraftWise deals with knowledge management and business intelligence that assists law firms to procure quality contracts swiftly. It enables clients to avail and customize the security according to their requirements. DraftWise was founded in 2020 by Emre Ozen, Ozan Yalti, and James Ding and was headquartered in New York.
- Ceartas DMCA — Ceartas is the leader in piracy protection for creators, brands & enterprise. Powered by AI, we have the highest removal rate in the industry
- Prothea Technologies — Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Education
Payments
Fashion
Organic Food
Social Media
Medical
Retail
Email
Art
Financial Services
Wellness
Music
Infrastructure
Mobile
Franchise
Social Network
Platforms
Local
Internet
Digital Media
Construction
Manufacturing
Mobile Advertising
eSports
Sports
Enterprise Software
Legal
Biotechnology
Android
Wine And Spirits
Medical Device
Hospitality
Crowdfunding
Social
Automotive
Fitness
CleanTech
Travel
Transportation
Mobile Apps
InsurTech
Enterprise
Recruiting
Cannabis
Renewable Energy
LGBT
Life Science
Theatre
Film
Non Profit
SaaS
Software
Sporting Goods
Restaurants
Social Impact
Celebrity
Cryptocurrency
Agriculture (agtech)
Facebook
Media (entertainment)
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Morocco
Czech Republic
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Gibraltar
Chile
Bermuda
Belize
Georgia
Greece
Egypt
Hungary
Malta
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Mali
Bulgaria
Bahrain
Malaysia
Turkey
Serbia
Rwanda
El Salvador
Venezuela
Italy
Ukraine
Portugal
Peru
Sierra Leone
Zimbabwe
Sweden
Taiwan
Lithuania
Senegal
Uruguay
Uganda
Myanmar
Tunisia
Lebanon
San Marino
Slovenia
Zambia
Uzbekistan
Russian Federation
Kuwait
Seychelles
Thailand
Cayman Islands
Puerto Rico
Tajikistan
Togo
Poland
Tanzania
Dominican Republic
Cambodia
Nigeria
Azerbaijan
Namibia
Iceland
Iraq
Bahamas
Israel
United Arab Emirates
Honduras
Panama
Bolivia
Isle of Man
Luxembourg
Mexico
Albania
Pakistan
Kazakhstan
Liberia
Jersey
Philippines
Grenada
Jordan
Romania
Norway
Argentina
Bangladesh
Mauritius
Kenya
Liechtenstein
Nicaragua
Latvia
Cyprus
Oman
Colombia
Austria
Cameroon
Switzerland
Guatemala
Marshall Islands
VC (Venture Capital) Funds in Germany by industry
Enterprise
FinTech
Consumer
Biotech
Health Care
Climate
Sustainability
Marketplace
SaaS
Community
Artificial intelligence
Hardware
Energy
Crowdfunding
Venture Capital
Restaurants
Real Estate
Fashion
Financial Services
Mobile Apps
Cryptocurrency
Education
Payments
Finance
Food and Beverage
Wine And Spirits
Video Games
Organic Food
Email
Medical
Social Network
Medical Device
Wellness
Social Media
Music
Art
Manufacturing
Digital Media
Blockchain
Android
Mobile
Construction
Local
Sports
Legal
Enterprise Software
Fitness
eSports
Travel
InsurTech
Hospitality
Automotive
Mobile Advertising
Recruiting
Cannabis
Biotechnology
Retail
Infrastructure
Beauty
Web3
Life Science
B2B
Photography
Big Data
Sporting Goods
Publishing
Clean Energy
Renewable Energy
Oil and Gas
CleanTech
EdTech
Social Impact
Impact
Social
Platforms
Agriculture (agtech)
Internet
Transportation
Media (entertainment)
Proptech
Software
Gaming